Edesa Biotech, Inc.EDSANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +6.94% | +66.18% | +117.97% | +120.78% | +138.33% |
| Weighted Average Shares Diluted Growth | +6.94% | +66.18% | +117.97% | +120.78% | +138.33% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -52.84% | -65.62% | -47.97% | +137.30% | +23.01% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -46.83% | +154.12% | +183.20% | +258.20% | +253.26% |
| Book Value per Share Growth | -63.78% | +116.24% | +126.13% | +184.68% | +158.62% |
| Debt Growth | -100.00% | -100.00% | -100.00% | -100.00% | +0.00% |
| R&D Expense Growth | +44.77% | -58.83% | +4.65% | +1079.92% | +10.29% |
| SG&A Expenses Growth | -20.68% | +15.60% | -6.81% | +38.22% | +38.43% |